COCH Envoy Medical, Inc.
Envoy Medical, Inc. (COCH) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: February 12, 2026 , by TAYLOR GLEN A .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| TAYLOR GLEN A | 10% Owner | Buy | 18,750,000 | $0.40 | $7.5M | 21,703,607 | |
| BRYNELSEN CHARLES | Director | Buy | 1,000,000 | $0.40 | $400.0K | 1,050,000 | |
| Patel Mona Chetan | Director | Buy | 312,500 | $0.40 | $125.0K | 332,500 | |
| Potashnick Robert | Interim CFO | Buy | 212,500 | $0.40 | $85.0K | 212,500 | |
| Kantor Susan | Director | Buy | 96,150 | $0.40 | $38.5K | 174,037 | |
| Lucas Brent T. | Chief Executive Officer | Buy | 62,500 | $0.40 | $25.0K | 297,090 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.